Walgreen Company Earnings: What to Expect Tuesday

The drugstore chain has faced rising competition from CVS and Rite Aid. Can Walgreen keep its growth up?

Mar 24, 2014 at 10:32AM

Walgreen (NASDAQ:WBA) will release its quarterly report on Tuesday, and investors have been optimistic about the drugstore chain operator's ability to continue posting solid growth. Yet as rivals CVS Caremark (NYSE:CVS) and Rite Aid (NYSE:RAD) aim to grab their shares of an expanding market, Walgreen needs to demonstrate its ability to take advantage of new opportunities like Obamacare and Medicaid expansion in a way that emphasizes its own competitive advantages.

Walgreen has been a leader in the drugstore space for years, having expanded its reach not only throughout the U.S. but also internationally through major strategic moves in Europe. Yet as drugstores become a potential focal point for delivering health care services locally, Walgreen, CVS, and Rite Aid are all looking for innovative ways to transform their U.S. stores to grab new opportunities. After recovering from a strategic mistake that caused extensive customer defections, can Walgreen move forward and capture its share of growth? Let's take an early look at what's been happening with Walgreen over the past quarter and what we're likely to see in its report.

Source: Wikimedia Commons.

Stats on Walgreen

Analyst EPS Estimate


Change From Year-Ago EPS


Revenue Estimate

$19.61 billion

Change From Year-Ago Revenue


Earnings Beats in Past 4 Quarters


Source: Yahoo! Finance.

What's next for Walgreen earnings?
In recent months, analysts have had mixed views on Walgreen earnings, cutting February-quarter estimates by 7% and reducing full-year fiscal 2014 projections slightly but raising their outlook for fiscal 2015. The stock has moved higher, rising 14% since mid-December.

Walgreen had a strong November quarter that built positive momentum for the stock. Total revenue climbed nearly 6%, sending adjusted net income up by almost 25%. Of particular value to Walgreen was a 5.8% jump in the number of prescriptions filled, indicating that customers have come back to the chain even after its near-disastrous spat with Express Scripts caused widespread customer defections. Cost-cutting measures also helped support earnings growth. Much of that good news has continued into the February quarter, with sales gains of 7% in December, 4% in January, and 5% in February.

But analysts aren't convinced that Walgreen stock hasn't outpaced its true potential. Just last week, Cantor Fitzgerald downgraded the stock, arguing that Walgreen hasn't produced enough growth to justify the jump in its share price over the past two years. That's consistent with actual sales-growth rates in the industry, where CVS has crushed both Rite Aid and Walgreen by taking a lower-margin approach to grabbing up business.

Still, Walgreen is working hard to find that growth. In January, Walgreen started offering free prescriptions to those who enrolled in insurance plans under the Affordable Care Act, even if they hadn't yet received their insurance ID cards. By doing so, Walgreen took advantage of some of Obamacare's growing pains, beating not only Rite Aid and CVS but also pharmacy rivals Costco and Wal-Mart in making a play for new Obamacare enrollees. In addition, the partnership with Alliance Boots and its newer collaboration with AmerisourceBergen has helped add to both sales and earnings.

One new angle that Walgreen faces comes from CVS' recent decision to stop selling cigarettes in its stores. CVS gave up billions in sales with the decision, but now Walgreen and Rite Aid are under pressure from dozens of state attorneys general who want the drugstores and other cigarette retailers to follow suit. It's unclear whether CVS will build up enough goodwill among its customer base to offset the lost sales or whether Walgreen and Rite Aid have an opportunity to poach customers due to the CVS decision.

In the Walgreen earnings report, watch to see whether the company talks about any further developments with respect to maximizing its Obamacare opportunity. With so much at stake from newly insured Americans, Walgreen needs to jump at the chance to grab new customers as they establish their loyalty to particular drugstore chains.

Learn more about Obamacare and your investments
Obamacare and its impact on your investments might seem complex, but it doesn't have to be. In only minutes, you can learn the critical facts you need to know in a special free report called "Everything You Need to Know About Obamacare." This FREE guide contains the key information and money-making advice that every American must know. Please click here to access your free copy.

Click here to add Walgreen to My Watchlist, which can find all of our Foolish analysis on it and all your other stocks.

Dan Caplinger has no position in any stocks mentioned. The Motley Fool recommends Costco Wholesale, CVS Caremark, and Express Scripts. The Motley Fool owns shares of Costco Wholesale and Express Scripts. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.

Compare Brokers